Clinical Trial Update: Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating olanzapine in combination with zonisamide sustained-release to prevent weight gain in patients with schizophrenia or schizoaff…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia
• Schizophreniform Disorder

Drugs mentioned

• Zonegran (zonisamide)
• Zyprexa (olanzapine)

Snippet

Sponsor: Orexigen Therapeutics, Inc | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 2 | Status: TERMINATED